01:53 AM EDT, 10/15/2026 (MT Newswires) -- Evotec (EVT.F) appointed Joanna Holbrook as chief scientific officer, with effect from Nov. 1. The life science company said Thursday that Holbrook most recently served as therapy area head, cardiovascular, renal and hepatic disease and head of in vitro discovery platforms at Danish pharmaceutical giant Novo Nordisk (NOVO-B.CO).

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.